nup184 Antibody

What is NUP188 and what role does it play in cellular function?

NUP188 functions as a critical component of the nuclear pore complex (NPC), a macromolecular assembly responsible for trafficking across the nuclear envelope. Research indicates that NUP188 is specifically required for proper protein transport into the nucleus . The protein is approximately 196 kDa in size and contributes to the structural integrity of the nuclear pore complex . Unlike some nucleoporins that can be found in both nuclear envelope-associated and intranuclear locations, NUP188 appears to be predominantly localized at the nuclear envelope, suggesting a more specialized structural role in nuclear transport .

How does NUP188 differ from other nucleoporins in terms of localization?

Unlike more dynamic nucleoporins such as Sec13 and Nup88 which have been detected at both the nuclear envelope and at intranuclear locations, NUP188 (like Nup154) has been observed exclusively at the nuclear envelope when studied in intact salivary gland nuclei . Immunofluorescence analysis with anti-Lamin antibody to mark the nuclear periphery has confirmed this restricted localization pattern. This suggests that NUP188 may function primarily as a structural component rather than participating directly in intranuclear gene regulatory activities exhibited by some other nucleoporins .

What are the common alternative names for NUP188 in scientific literature?

When searching for research on NUP188, it's important to be aware of its alternative nomenclature. The protein is also referred to as KIAA0169, hNup188, Nucleoporin 188kDa, and Nucleoporin NUP188 homolog in various publications and databases . Additional identifiers include BC025526, FLJ21639, mKIAA0169, OTTMUSP00000018197, RP11-167N5.2, RP23-395P6.3, and U89435 . Being familiar with these alternative designations is essential for comprehensive literature searches and avoiding redundancy in research.

What critical factors should be considered when selecting a NUP188 antibody?

When selecting a NUP188 antibody, researchers should consider several key factors. First, evaluate the immunogen used for antibody generation - for example, some antibodies are raised against recombinant fragments within specific amino acid regions (e.g., aa 250-400) of human NUP188 . Second, confirm the antibody's species reactivity, as some are specific to human samples while others may cross-react with mouse or other species . Third, verify the validated applications, whether you need an antibody for IHC-P, ICC/IF, or other techniques . Finally, consider the clonality - most available NUP188 antibodies are rabbit polyclonal, which offers robust detection but may have batch-to-batch variation compared to monoclonals .

How should NUP188 antibody specificity be validated for nuclear pore complex research?

Validating NUP188 antibody specificity requires a multi-faceted approach. Begin with western blotting to confirm detection of a single band at the expected molecular weight of approximately 196 kDa . For immunofluorescence applications, co-staining with established nuclear envelope markers (such as anti-Lamin antibodies) can confirm the expected nuclear envelope localization pattern . As a negative control, use tissues or cells known to have low NUP188 expression. For definitive validation, compare staining patterns with multiple antibodies targeting different epitopes of NUP188, or perform knockdown/knockout experiments to confirm loss of signal. When studying multiple nuclear pore components simultaneously, validate that your NUP188 antibody doesn't cross-react with other nucleoporins by using immunoprecipitation followed by mass spectrometry.

What dilution ranges are typically effective for NUP188 antibodies in different applications?

The optimal antibody dilution varies by application technique and the specific antibody formulation:

These ranges should serve as starting points, with specific optimization required for each experimental system and antibody . Empirical testing with serial dilutions is recommended to determine the optimal signal-to-noise ratio for your specific tissue or cell type.

What fixation and permeabilization methods work best for NUP188 detection in immunofluorescence?

For optimal NUP188 detection in immunofluorescence applications, paraformaldehyde fixation (typically 4%) has been successfully employed in studies of SiHa cells . This fixation method preserves cellular architecture while maintaining NUP188 antigenicity. Following fixation, permeabilization with either 0.1-0.5% Triton X-100 or 0.1-0.3% Saponin is recommended to allow antibody access to the nuclear envelope components. For studies requiring visualization of both NUP188 and chromatin interactions, methods used for polytene chromosome spreads may be adapted, which involve careful fixation to maintain both protein localization and chromosome structure . When detecting NUP188 alongside other nuclear envelope components, avoid methanol fixation as it can disrupt the nuclear membrane structure and alter the apparent distribution of nuclear pore complex proteins.

How should samples be prepared for NUP188 detection in immunohistochemistry?

For immunohistochemical detection of NUP188, paraffin-embedded tissue sections have been successfully used with antibodies like ab204490 . The recommended protocol involves:

• Deparaffinization of tissue sections using xylene and rehydration through graded alcohols

• Antigen retrieval, preferably using heat-induced epitope retrieval in citrate buffer (pH 6.0) or EDTA buffer (pH 9.0)

• Blocking of endogenous peroxidase activity with 3% hydrogen peroxide

• Protein blocking with 5-10% normal serum

• Overnight incubation with primary NUP188 antibody at 4°C using dilutions between 1:20 and 1:200

• Detection using an appropriate secondary antibody and visualization system

What controls are essential when studying NUP188 localization at the nuclear envelope?

When investigating NUP188 localization, several controls are essential:

• Positive controls: Include tissues or cell lines known to express NUP188, such as human endometrium or SiHa cells .

• Negative controls: Omit primary antibody while maintaining all other steps to identify non-specific binding of secondary antibodies.

• Co-localization markers: Use established nuclear envelope markers such as anti-Lamin antibodies to confirm proper nuclear envelope staining .

• Comparative controls: Include other nucleoporins with different localization patterns (e.g., Nup88 or Sec13 which show both nuclear envelope and intranuclear localization) to distinguish NUP188's specific distribution pattern .

• Z-stack confocal imaging: Perform three-dimensional reconstructions from multiple z-stacks to accurately assess the spatial relationship between NUP188 staining and the nuclear envelope .

These controls help distinguish between specific NUP188 staining at the nuclear envelope and potential artifacts or cross-reactivity with other nuclear structures.

How can non-specific background staining be reduced when using NUP188 antibodies?

Non-specific background can be minimized through several optimized approaches:

• Antibody titration: Carefully optimize antibody dilution; using NUP188 antibodies at 1:50-1:200 for IHC or 4 μg/ml for ICC/IF has been reported to provide specific staining .

• Blocking optimization: Extend the blocking step using 5-10% serum from the same species as the secondary antibody, and consider adding 0.1-0.3% Triton X-100 to reduce hydrophobic interactions.

• Buffer formulation: Use TBS with 0.05-0.1% Tween-20 rather than PBS for wash steps, as phosphate buffers can sometimes increase background with certain antibodies.

• Secondary antibody selection: Use highly cross-adsorbed secondary antibodies specific to the host species of your NUP188 primary antibody (typically rabbit for available NUP188 antibodies) .

• Tissue preparation: For fixed tissues, ensure complete deparaffinization and optimize antigen retrieval conditions (duration, temperature, and buffer composition).

If background persists despite these measures, consider antibody purification methods such as peptide affinity chromatography, which has been used successfully for NUP188 antibody preparation .

What approaches can differentiate between NUP188 and other closely related nucleoporins?

Distinguishing NUP188 from other nucleoporins requires specific methodological considerations:

• Epitope mapping: Select antibodies raised against unique regions of NUP188 that don't share homology with other nucleoporins. Antibodies targeting amino acids 250-400 of human NUP188 have shown specificity .

• Co-localization studies: Perform double or triple immunofluorescence labeling with antibodies against different nucleoporins that show distinct localization patterns, such as Nup154 (exclusive nuclear envelope localization) versus Sec13 or Nup88 (both envelope and intranuclear localization) .

• Subcellular fractionation: Combine biochemical fractionation with immunoblotting to compare the distribution of NUP188 with other nucleoporins across nuclear envelope, nucleoplasmic, and chromatin-bound fractions.

• Super-resolution microscopy: Techniques like STED or STORM can resolve the spatial arrangement of different nucleoporins within the nuclear pore complex that conventional microscopy cannot distinguish.

• Proximity labeling: Methods like BioID or APEX2 fused to NUP188 can identify its nearest neighbors in the nuclear pore complex and distinguish its interactions from those of other nucleoporins.

How can researchers study dynamic interactions between NUP188 and chromatin?

To investigate NUP188's potential interactions with chromatin:

• Chromatin immunoprecipitation (ChIP): Use validated NUP188 antibodies to immunoprecipitate chromatin fragments, followed by sequencing to identify genomic binding sites. This approach has been used for other nucleoporins shown to interact with chromatin .

• Proximity ligation assay (PLA): This technique can detect close associations between NUP188 and specific chromatin proteins or modified histones in situ with higher sensitivity than conventional co-localization.

• Live-cell imaging: Employing fluorescently tagged NUP188 in combination with labeled chromatin markers can reveal dynamic interactions during different cell cycle phases or cellular states.

• DamID or APEX2 proximity labeling: Fusing DNA adenine methyltransferase or APEX2 to NUP188 can map chromatin regions in close proximity to NUP188 without crosslinking artifacts.

• Polytene chromosome binding: Following the approaches used for other nucleoporins, immunofluorescence on polytene chromosome spreads can reveal specific chromatin-binding sites for NUP188, if they exist .

It's important to note that based on current research, NUP188 appears to be predominantly localized to the nuclear envelope rather than showing the intranuclear chromatin associations observed with some other nucleoporins .

How does NUP188 contribute to nuclear transport regulation in different cellular contexts?

NUP188 plays a crucial role in nuclear transport processes, with its contributions varying across cellular contexts. As a stable component of the nuclear pore complex, NUP188 is required for proper protein transport into the nucleus . Unlike more dynamic nucleoporins that may shuttle between the nuclear envelope and intranuclear locations, NUP188 appears to maintain a more consistent presence at the nuclear envelope . This suggests it may provide structural support for the nuclear pore complex rather than directly participating in cargo binding. In specialized cells with high nuclear transport demands, such as actively secreting cells or rapidly dividing cancer cells, NUP188's role may be particularly important for maintaining efficient nuclear-cytoplasmic communication. Future research comparing NUP188 function across different cell types and physiological states will likely reveal context-specific contributions to nuclear transport regulation.

How might novel antibody technologies enhance NUP188 research?

Recent advances in antibody technology could significantly enhance NUP188 research. The development of llama-derived nanobodies, which are approximately one-tenth the size of conventional antibodies, represents a promising direction . While the search results specifically mention nanobodies for HIV research, the principles could be applied to create NUP188-targeting nanobodies. These smaller antibody fragments could potentially:

• Achieve better penetration into nuclear pore complexes for super-resolution imaging

• Access epitopes unavailable to conventional antibodies

• Enable live-cell imaging with reduced steric hindrance

• Facilitate multiplex imaging of multiple nucleoporins simultaneously

Additionally, engineering approaches like creating triple tandem formats of antibody fragments could be adapted to enhance the avidity and specificity of NUP188 detection. The development of antibodies that can distinguish between different conformational states or post-translational modifications of NUP188 would also advance understanding of its regulatory mechanisms.

How does NUP188 function differ from other members of the Nup93/205 sub-complex?

NUP188 belongs to the stable Nup93/205 sub-complex of the nuclear pore complex, alongside nucleoporins like Nup154 . This sub-complex plays a structural role in the nuclear pore architecture. Comparative analysis indicates that while both Nup154 and NUP188 are considered stable components, they may have distinct functional properties. Immunofluorescence studies on polytene chromosomes have revealed that Nup154, like NUP188, exclusively localizes to the nuclear envelope and is not detectable at chromosome sites . This contrasts with members of other sub-complexes such as the Nup107/160 sub-complex (including Sec13) or components like Nup88, which demonstrate both nuclear envelope and intranuclear localization . The exclusive nuclear envelope localization of NUP188 and Nup154 suggests these proteins may be primarily involved in structural maintenance of the nuclear pore complex rather than direct participation in gene regulation activities exhibited by some other nucleoporins.

What methodological approaches can differentiate between intranuclear and nuclear envelope pools of nucleoporins?

To distinguish between nucleoporins that are exclusively found at the nuclear envelope (like NUP188) versus those with dual localization patterns:

• Three-dimensional confocal microscopy: Performing indirect immunofluorescence on intact nuclei using specific nucleoporin antibodies combined with nuclear envelope markers such as anti-Lamin antibodies. Three-dimensional reconstructions from multiple z-stacks allow visualization of spatial relationships between nucleoporin signals and the nuclear envelope .

• Co-localization analysis: Quantitative co-localization with established markers of the nuclear envelope versus intranuclear regions can determine the distribution profile of nucleoporins.

• Biochemical fractionation: Sequential extraction protocols that separate nuclear envelope fractions from nucleoplasmic and chromatin-bound fractions, followed by western blotting for specific nucleoporins.

• Immunogold electron microscopy: This technique provides nanometer-scale resolution to precisely localize nucleoporins relative to nuclear pore structures and intranuclear regions.

• Chromatin immunoprecipitation: For nucleoporins with potential chromatin interactions, ChIP can identify genomic binding sites, which would be absent for exclusively nuclear envelope-bound nucleoporins like NUP188 .

These methodologies have revealed that while nucleoporins like Sec13 and Nup88 have significant intranuclear pools that may participate in gene regulation, NUP188 appears to be restricted to the nuclear envelope .